RE:RE:"Griproom" article - 10 signs your company is to be acquiredRoche & PDAC. The post I was referring to was Noteable and the Morpheus Trial. NCT03193190
This trial certainly reinforces the notion that Roche is a serous PDAC player. I agree that pela could fit, and one would assume it would not take ages to be inserted into Morpheus.
From my lay perspective, I think they should be treating PDAC patients with the biomarkers with Pela right now. Hurry up.